nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—breast cancer—colon cancer	0.756	1	CtDrD
Raloxifene—AOX1—Methotrexate—colon cancer	0.0771	0.545	CbGbCtD
Raloxifene—CYP2B6—Irinotecan—colon cancer	0.028	0.198	CbGbCtD
Raloxifene—CYP2C8—Fluorouracil—colon cancer	0.0203	0.144	CbGbCtD
Raloxifene—CYP3A4—Irinotecan—colon cancer	0.0086	0.0607	CbGbCtD
Raloxifene—CYP3A4—Vincristine—colon cancer	0.00751	0.0531	CbGbCtD
Raloxifene—Retinal vein thrombosis—Methotrexate—colon cancer	0.00287	0.0496	CcSEcCtD
Raloxifene—Thromboembolic event—Irinotecan—colon cancer	0.00224	0.0388	CcSEcCtD
Raloxifene—Coronary artery disease—Vincristine—colon cancer	0.00157	0.0271	CcSEcCtD
Raloxifene—Thromboembolic event—Capecitabine—colon cancer	0.0015	0.0259	CcSEcCtD
Raloxifene—AOX1—gall bladder—colon cancer	0.00137	0.0647	CbGeAlD
Raloxifene—EBP—liver—colon cancer	0.0012	0.0566	CbGeAlD
Raloxifene—Thromboembolic event—Methotrexate—colon cancer	0.00112	0.0193	CcSEcCtD
Raloxifene—Varicose vein—Capecitabine—colon cancer	0.00108	0.0188	CcSEcCtD
Raloxifene—ESR1—blood vessel—colon cancer	0.00104	0.0489	CbGeAlD
Raloxifene—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.000983	0.017	CcSEcCtD
Raloxifene—Embolism—Irinotecan—colon cancer	0.00094	0.0163	CcSEcCtD
Raloxifene—ESR2—epithelium—colon cancer	0.000736	0.0348	CbGeAlD
Raloxifene—ESR2—smooth muscle tissue—colon cancer	0.000709	0.0335	CbGeAlD
Raloxifene—Neoplasm malignant—Irinotecan—colon cancer	0.000706	0.0122	CcSEcCtD
Raloxifene—Vasodilation—Irinotecan—colon cancer	0.000687	0.0119	CcSEcCtD
Raloxifene—Vasodilation procedure—Irinotecan—colon cancer	0.000687	0.0119	CcSEcCtD
Raloxifene—ESR2—renal system—colon cancer	0.000683	0.0323	CbGeAlD
Raloxifene—Deep vein thrombosis—Capecitabine—colon cancer	0.000664	0.0115	CcSEcCtD
Raloxifene—Tenderness—Fluorouracil—colon cancer	0.000662	0.0115	CcSEcCtD
Raloxifene—Cough increased—Irinotecan—colon cancer	0.000659	0.0114	CcSEcCtD
Raloxifene—AOX1—renal system—colon cancer	0.000657	0.031	CbGeAlD
Raloxifene—Embolism—Capecitabine—colon cancer	0.000629	0.0109	CcSEcCtD
Raloxifene—ESR1—embryo—colon cancer	0.000618	0.0292	CbGeAlD
Raloxifene—Pulmonary embolism—Irinotecan—colon cancer	0.000603	0.0104	CcSEcCtD
Raloxifene—Neuralgia—Capecitabine—colon cancer	0.000581	0.0101	CcSEcCtD
Raloxifene—ESR2—lymphoid tissue—colon cancer	0.000567	0.0268	CbGeAlD
Raloxifene—Laryngitis—Capecitabine—colon cancer	0.00056	0.00969	CcSEcCtD
Raloxifene—ESR2—digestive system—colon cancer	0.00056	0.0265	CbGeAlD
Raloxifene—SIGMAR1—smooth muscle tissue—colon cancer	0.00055	0.026	CbGeAlD
Raloxifene—HTR2B—smooth muscle tissue—colon cancer	0.000548	0.0259	CbGeAlD
Raloxifene—Vaginal haemorrhage—Capecitabine—colon cancer	0.000546	0.00944	CcSEcCtD
Raloxifene—AOX1—digestive system—colon cancer	0.000539	0.0255	CbGeAlD
Raloxifene—ESR1—epithelium—colon cancer	0.000504	0.0238	CbGeAlD
Raloxifene—ESR2—vagina—colon cancer	0.000495	0.0234	CbGeAlD
Raloxifene—Deep vein thrombosis—Methotrexate—colon cancer	0.000494	0.00855	CcSEcCtD
Raloxifene—Vaginal discharge—Methotrexate—colon cancer	0.000494	0.00855	CcSEcCtD
Raloxifene—ESR1—smooth muscle tissue—colon cancer	0.000486	0.0229	CbGeAlD
Raloxifene—AOX1—vagina—colon cancer	0.000476	0.0225	CbGeAlD
Raloxifene—Embolism—Methotrexate—colon cancer	0.000468	0.0081	CcSEcCtD
Raloxifene—ESR1—renal system—colon cancer	0.000468	0.0221	CbGeAlD
Raloxifene—Cerebrovascular accident—Irinotecan—colon cancer	0.000447	0.00773	CcSEcCtD
Raloxifene—HTR2B—digestive system—colon cancer	0.000433	0.0205	CbGeAlD
Raloxifene—ESR2—liver—colon cancer	0.000417	0.0197	CbGeAlD
Raloxifene—Aspartate aminotransferase increased—Vincristine—colon cancer	0.000405	0.00701	CcSEcCtD
Raloxifene—Pulmonary embolism—Capecitabine—colon cancer	0.000404	0.00699	CcSEcCtD
Raloxifene—Blood pressure increased—Capecitabine—colon cancer	0.000404	0.00699	CcSEcCtD
Raloxifene—AOX1—liver—colon cancer	0.000402	0.019	CbGeAlD
Raloxifene—SIGMAR1—bone marrow—colon cancer	0.0004	0.0189	CbGeAlD
Raloxifene—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.000394	0.00682	CcSEcCtD
Raloxifene—ESR1—lymphoid tissue—colon cancer	0.000388	0.0183	CbGeAlD
Raloxifene—CYP2C8—renal system—colon cancer	0.000385	0.0182	CbGeAlD
Raloxifene—ESR1—digestive system—colon cancer	0.000384	0.0181	CbGeAlD
Raloxifene—SIGMAR1—vagina—colon cancer	0.000383	0.0181	CbGeAlD
Raloxifene—HTR2B—vagina—colon cancer	0.000382	0.0181	CbGeAlD
Raloxifene—Pneumonia—Vincristine—colon cancer	0.000349	0.00603	CcSEcCtD
Raloxifene—CYP2B6—renal system—colon cancer	0.000346	0.0163	CbGeAlD
Raloxifene—Depression—Vincristine—colon cancer	0.000346	0.00598	CcSEcCtD
Raloxifene—Pneumonia—Irinotecan—colon cancer	0.000339	0.00587	CcSEcCtD
Raloxifene—ESR1—vagina—colon cancer	0.000339	0.016	CbGeAlD
Raloxifene—Diabetes mellitus—Capecitabine—colon cancer	0.000337	0.00583	CcSEcCtD
Raloxifene—Sweating—Vincristine—colon cancer	0.000332	0.00575	CcSEcCtD
Raloxifene—Gastroenteritis—Capecitabine—colon cancer	0.000331	0.00572	CcSEcCtD
Raloxifene—CYP19A1—liver—colon cancer	0.000329	0.0155	CbGeAlD
Raloxifene—Pneumonia—Fluorouracil—colon cancer	0.000325	0.00563	CcSEcCtD
Raloxifene—Sweating—Irinotecan—colon cancer	0.000324	0.0056	CcSEcCtD
Raloxifene—SIGMAR1—liver—colon cancer	0.000323	0.0153	CbGeAlD
Raloxifene—ESR2—lymph node—colon cancer	0.00032	0.0151	CbGeAlD
Raloxifene—Urinary tract infection—Fluorouracil—colon cancer	0.000314	0.00544	CcSEcCtD
Raloxifene—Conjunctivitis—Fluorouracil—colon cancer	0.000314	0.00544	CcSEcCtD
Raloxifene—Hot flush—Capecitabine—colon cancer	0.000313	0.00542	CcSEcCtD
Raloxifene—Menopausal symptoms—Capecitabine—colon cancer	0.000311	0.00538	CcSEcCtD
Raloxifene—Hypoaesthesia—Vincristine—colon cancer	0.00031	0.00536	CcSEcCtD
Raloxifene—AOX1—lymph node—colon cancer	0.000308	0.0145	CbGeAlD
Raloxifene—Urinary tract disorder—Vincristine—colon cancer	0.000307	0.00532	CcSEcCtD
Raloxifene—Connective tissue disorder—Vincristine—colon cancer	0.000306	0.00529	CcSEcCtD
Raloxifene—Urethral disorder—Vincristine—colon cancer	0.000305	0.00528	CcSEcCtD
Raloxifene—Rhinitis—Irinotecan—colon cancer	0.000304	0.00526	CcSEcCtD
Raloxifene—Sinusitis—Fluorouracil—colon cancer	0.000303	0.00525	CcSEcCtD
Raloxifene—Arthritis—Capecitabine—colon cancer	0.000302	0.00522	CcSEcCtD
Raloxifene—Pulmonary embolism—Methotrexate—colon cancer	0.000301	0.0052	CcSEcCtD
Raloxifene—Vaginal inflammation—Methotrexate—colon cancer	0.000301	0.0052	CcSEcCtD
Raloxifene—Cerebrovascular accident—Capecitabine—colon cancer	0.000299	0.00518	CcSEcCtD
Raloxifene—Connective tissue disorder—Irinotecan—colon cancer	0.000298	0.00515	CcSEcCtD
Raloxifene—Cystitis noninfective—Methotrexate—colon cancer	0.000294	0.00508	CcSEcCtD
Raloxifene—Rhinitis—Fluorouracil—colon cancer	0.000291	0.00503	CcSEcCtD
Raloxifene—Cystitis—Methotrexate—colon cancer	0.00029	0.00502	CcSEcCtD
Raloxifene—Cardiac disorder—Vincristine—colon cancer	0.000289	0.005	CcSEcCtD
Raloxifene—Hypoaesthesia—Fluorouracil—colon cancer	0.000289	0.005	CcSEcCtD
Raloxifene—Migraine—Capecitabine—colon cancer	0.000288	0.00499	CcSEcCtD
Raloxifene—Pharyngitis—Fluorouracil—colon cancer	0.000288	0.00498	CcSEcCtD
Raloxifene—CYP2B6—lymphoid tissue—colon cancer	0.000287	0.0136	CbGeAlD
Raloxifene—ESR1—liver—colon cancer	0.000286	0.0135	CbGeAlD
Raloxifene—Vaginal infection—Methotrexate—colon cancer	0.000284	0.00491	CcSEcCtD
Raloxifene—CYP2B6—digestive system—colon cancer	0.000283	0.0134	CbGeAlD
Raloxifene—Angiopathy—Vincristine—colon cancer	0.000282	0.00488	CcSEcCtD
Raloxifene—Flushing—Irinotecan—colon cancer	0.000281	0.00487	CcSEcCtD
Raloxifene—Cardiac disorder—Irinotecan—colon cancer	0.000281	0.00487	CcSEcCtD
Raloxifene—CYP2C8—vagina—colon cancer	0.000279	0.0132	CbGeAlD
Raloxifene—Angiopathy—Irinotecan—colon cancer	0.000275	0.00476	CcSEcCtD
Raloxifene—Bladder pain—Methotrexate—colon cancer	0.000272	0.0047	CcSEcCtD
Raloxifene—Breast disorder—Capecitabine—colon cancer	0.000265	0.00458	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000264	0.00457	CcSEcCtD
Raloxifene—CYP3A4—renal system—colon cancer	0.000261	0.0123	CbGeAlD
Raloxifene—Flatulence—Irinotecan—colon cancer	0.00026	0.0045	CcSEcCtD
Raloxifene—Muscle spasms—Irinotecan—colon cancer	0.000254	0.00439	CcSEcCtD
Raloxifene—Influenza—Capecitabine—colon cancer	0.000253	0.00438	CcSEcCtD
Raloxifene—CYP19A1—lymph node—colon cancer	0.000252	0.0119	CbGeAlD
Raloxifene—Diabetes mellitus—Methotrexate—colon cancer	0.000251	0.00434	CcSEcCtD
Raloxifene—CYP2B6—vagina—colon cancer	0.00025	0.0118	CbGeAlD
Raloxifene—SIGMAR1—lymph node—colon cancer	0.000248	0.0117	CbGeAlD
Raloxifene—HTR2B—lymph node—colon cancer	0.000247	0.0117	CbGeAlD
Raloxifene—Bronchitis—Capecitabine—colon cancer	0.000244	0.00422	CcSEcCtD
Raloxifene—Vertigo—Vincristine—colon cancer	0.000243	0.00421	CcSEcCtD
Raloxifene—Vertigo—Irinotecan—colon cancer	0.000237	0.0041	CcSEcCtD
Raloxifene—Syncope—Irinotecan—colon cancer	0.000236	0.00409	CcSEcCtD
Raloxifene—CYP2C8—liver—colon cancer	0.000235	0.0111	CbGeAlD
Raloxifene—Loss of consciousness—Irinotecan—colon cancer	0.000232	0.00401	CcSEcCtD
Raloxifene—Myalgia—Vincristine—colon cancer	0.000231	0.00399	CcSEcCtD
Raloxifene—Weight increased—Capecitabine—colon cancer	0.000231	0.00399	CcSEcCtD
Raloxifene—Cough—Irinotecan—colon cancer	0.00023	0.00398	CcSEcCtD
Raloxifene—Pneumonia—Capecitabine—colon cancer	0.000227	0.00393	CcSEcCtD
Raloxifene—Depression—Capecitabine—colon cancer	0.000225	0.0039	CcSEcCtD
Raloxifene—Cerebrovascular accident—Methotrexate—colon cancer	0.000223	0.00385	CcSEcCtD
Raloxifene—Infection—Vincristine—colon cancer	0.00022	0.0038	CcSEcCtD
Raloxifene—Urinary tract infection—Capecitabine—colon cancer	0.00022	0.0038	CcSEcCtD
Raloxifene—Conjunctivitis—Capecitabine—colon cancer	0.00022	0.0038	CcSEcCtD
Raloxifene—ESR1—lymph node—colon cancer	0.000219	0.0103	CbGeAlD
Raloxifene—Nervous system disorder—Vincristine—colon cancer	0.000217	0.00375	CcSEcCtD
Raloxifene—Thrombocytopenia—Vincristine—colon cancer	0.000216	0.00374	CcSEcCtD
Raloxifene—Chest pain—Fluorouracil—colon cancer	0.000215	0.00372	CcSEcCtD
Raloxifene—Myalgia—Fluorouracil—colon cancer	0.000215	0.00372	CcSEcCtD
Raloxifene—CYP3A4—digestive system—colon cancer	0.000214	0.0101	CbGeAlD
Raloxifene—Infection—Irinotecan—colon cancer	0.000214	0.0037	CcSEcCtD
Raloxifene—Hyperhidrosis—Vincristine—colon cancer	0.000214	0.0037	CcSEcCtD
Raloxifene—Shock—Irinotecan—colon cancer	0.000212	0.00366	CcSEcCtD
Raloxifene—CYP2B6—liver—colon cancer	0.000211	0.00997	CbGeAlD
Raloxifene—Nervous system disorder—Irinotecan—colon cancer	0.000211	0.00365	CcSEcCtD
Raloxifene—Thrombocytopenia—Irinotecan—colon cancer	0.000211	0.00365	CcSEcCtD
Raloxifene—Hyperhidrosis—Irinotecan—colon cancer	0.000208	0.0036	CcSEcCtD
Raloxifene—Infection—Fluorouracil—colon cancer	0.000205	0.00354	CcSEcCtD
Raloxifene—Rhinitis—Capecitabine—colon cancer	0.000203	0.00352	CcSEcCtD
Raloxifene—Nervous system disorder—Fluorouracil—colon cancer	0.000202	0.0035	CcSEcCtD
Raloxifene—Thrombocytopenia—Fluorouracil—colon cancer	0.000202	0.00349	CcSEcCtD
Raloxifene—Hypoaesthesia—Capecitabine—colon cancer	0.000202	0.00349	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Vincristine—colon cancer	0.000201	0.00348	CcSEcCtD
Raloxifene—Pharyngitis—Capecitabine—colon cancer	0.000201	0.00348	CcSEcCtD
Raloxifene—Urinary tract disorder—Capecitabine—colon cancer	0.0002	0.00347	CcSEcCtD
Raloxifene—Insomnia—Vincristine—colon cancer	0.0002	0.00346	CcSEcCtD
Raloxifene—Oedema peripheral—Capecitabine—colon cancer	0.0002	0.00346	CcSEcCtD
Raloxifene—Connective tissue disorder—Capecitabine—colon cancer	0.000199	0.00345	CcSEcCtD
Raloxifene—Urethral disorder—Capecitabine—colon cancer	0.000199	0.00344	CcSEcCtD
Raloxifene—Breast disorder—Methotrexate—colon cancer	0.000197	0.00341	CcSEcCtD
Raloxifene—Insomnia—Irinotecan—colon cancer	0.000195	0.00337	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Vincristine—colon cancer	0.000191	0.0033	CcSEcCtD
Raloxifene—Dyspepsia—Irinotecan—colon cancer	0.000189	0.00328	CcSEcCtD
Raloxifene—Pain—Vincristine—colon cancer	0.000189	0.00327	CcSEcCtD
Raloxifene—Flushing—Capecitabine—colon cancer	0.000188	0.00326	CcSEcCtD
Raloxifene—Cardiac disorder—Capecitabine—colon cancer	0.000188	0.00326	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000188	0.00325	CcSEcCtD
Raloxifene—Insomnia—Fluorouracil—colon cancer	0.000186	0.00323	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Irinotecan—colon cancer	0.000186	0.00322	CcSEcCtD
Raloxifene—Pain—Irinotecan—colon cancer	0.000184	0.00319	CcSEcCtD
Raloxifene—Angiopathy—Capecitabine—colon cancer	0.000184	0.00318	CcSEcCtD
Raloxifene—Dyspepsia—Fluorouracil—colon cancer	0.000181	0.00314	CcSEcCtD
Raloxifene—Gastrointestinal pain—Vincristine—colon cancer	0.000181	0.00313	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000178	0.00308	CcSEcCtD
Raloxifene—Pain—Fluorouracil—colon cancer	0.000176	0.00305	CcSEcCtD
Raloxifene—Gastrointestinal pain—Irinotecan—colon cancer	0.000176	0.00305	CcSEcCtD
Raloxifene—Abdominal pain—Vincristine—colon cancer	0.000175	0.00302	CcSEcCtD
Raloxifene—Body temperature increased—Vincristine—colon cancer	0.000175	0.00302	CcSEcCtD
Raloxifene—Flatulence—Capecitabine—colon cancer	0.000174	0.00301	CcSEcCtD
Raloxifene—Body temperature increased—Irinotecan—colon cancer	0.00017	0.00294	CcSEcCtD
Raloxifene—Abdominal pain—Irinotecan—colon cancer	0.00017	0.00294	CcSEcCtD
Raloxifene—Muscle spasms—Capecitabine—colon cancer	0.00017	0.00294	CcSEcCtD
Raloxifene—Pneumonia—Methotrexate—colon cancer	0.000169	0.00293	CcSEcCtD
Raloxifene—Depression—Methotrexate—colon cancer	0.000168	0.0029	CcSEcCtD
Raloxifene—Conjunctivitis—Methotrexate—colon cancer	0.000163	0.00283	CcSEcCtD
Raloxifene—Body temperature increased—Fluorouracil—colon cancer	0.000163	0.00282	CcSEcCtD
Raloxifene—Sweating—Methotrexate—colon cancer	0.000161	0.00279	CcSEcCtD
Raloxifene—CYP3A4—liver—colon cancer	0.000159	0.00753	CbGeAlD
Raloxifene—Vertigo—Capecitabine—colon cancer	0.000159	0.00274	CcSEcCtD
Raloxifene—Syncope—Capecitabine—colon cancer	0.000158	0.00274	CcSEcCtD
Raloxifene—Loss of consciousness—Capecitabine—colon cancer	0.000155	0.00268	CcSEcCtD
Raloxifene—Cough—Capecitabine—colon cancer	0.000154	0.00267	CcSEcCtD
Raloxifene—Diarrhoea—Vincristine—colon cancer	0.000151	0.00262	CcSEcCtD
Raloxifene—Arthralgia—Capecitabine—colon cancer	0.00015	0.0026	CcSEcCtD
Raloxifene—Chest pain—Capecitabine—colon cancer	0.00015	0.0026	CcSEcCtD
Raloxifene—Myalgia—Capecitabine—colon cancer	0.00015	0.0026	CcSEcCtD
Raloxifene—Pharyngitis—Methotrexate—colon cancer	0.00015	0.00259	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000149	0.00258	CcSEcCtD
Raloxifene—Urinary tract disorder—Methotrexate—colon cancer	0.000149	0.00258	CcSEcCtD
Raloxifene—Urethral disorder—Methotrexate—colon cancer	0.000148	0.00256	CcSEcCtD
Raloxifene—Diarrhoea—Irinotecan—colon cancer	0.000147	0.00255	CcSEcCtD
Raloxifene—Dizziness—Vincristine—colon cancer	0.000146	0.00253	CcSEcCtD
Raloxifene—Infection—Capecitabine—colon cancer	0.000143	0.00248	CcSEcCtD
Raloxifene—Dizziness—Irinotecan—colon cancer	0.000142	0.00246	CcSEcCtD
Raloxifene—Shock—Capecitabine—colon cancer	0.000142	0.00245	CcSEcCtD
Raloxifene—Nervous system disorder—Capecitabine—colon cancer	0.000141	0.00244	CcSEcCtD
Raloxifene—Diarrhoea—Fluorouracil—colon cancer	0.000141	0.00244	CcSEcCtD
Raloxifene—Thrombocytopenia—Capecitabine—colon cancer	0.000141	0.00244	CcSEcCtD
Raloxifene—Vomiting—Vincristine—colon cancer	0.000141	0.00243	CcSEcCtD
Raloxifene—Cardiac disorder—Methotrexate—colon cancer	0.00014	0.00242	CcSEcCtD
Raloxifene—Skin disorder—Capecitabine—colon cancer	0.00014	0.00242	CcSEcCtD
Raloxifene—Rash—Vincristine—colon cancer	0.000139	0.00241	CcSEcCtD
Raloxifene—Hyperhidrosis—Capecitabine—colon cancer	0.000139	0.00241	CcSEcCtD
Raloxifene—Dermatitis—Vincristine—colon cancer	0.000139	0.00241	CcSEcCtD
Raloxifene—Headache—Vincristine—colon cancer	0.000138	0.0024	CcSEcCtD
Raloxifene—Angiopathy—Methotrexate—colon cancer	0.000137	0.00237	CcSEcCtD
Raloxifene—Vomiting—Irinotecan—colon cancer	0.000137	0.00237	CcSEcCtD
Raloxifene—Dizziness—Fluorouracil—colon cancer	0.000136	0.00236	CcSEcCtD
Raloxifene—Rash—Irinotecan—colon cancer	0.000136	0.00235	CcSEcCtD
Raloxifene—Dermatitis—Irinotecan—colon cancer	0.000136	0.00235	CcSEcCtD
Raloxifene—Headache—Irinotecan—colon cancer	0.000135	0.00233	CcSEcCtD
Raloxifene—Nausea—Vincristine—colon cancer	0.000131	0.00227	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000131	0.00227	CcSEcCtD
Raloxifene—Vomiting—Fluorouracil—colon cancer	0.000131	0.00227	CcSEcCtD
Raloxifene—Insomnia—Capecitabine—colon cancer	0.00013	0.00225	CcSEcCtD
Raloxifene—Rash—Fluorouracil—colon cancer	0.00013	0.00225	CcSEcCtD
Raloxifene—Dermatitis—Fluorouracil—colon cancer	0.00013	0.00225	CcSEcCtD
Raloxifene—Headache—Fluorouracil—colon cancer	0.000129	0.00223	CcSEcCtD
Raloxifene—Nausea—Irinotecan—colon cancer	0.000128	0.00221	CcSEcCtD
Raloxifene—Dyspepsia—Capecitabine—colon cancer	0.000127	0.00219	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Capecitabine—colon cancer	0.000124	0.00215	CcSEcCtD
Raloxifene—Pain—Capecitabine—colon cancer	0.000123	0.00213	CcSEcCtD
Raloxifene—Nausea—Fluorouracil—colon cancer	0.000122	0.00212	CcSEcCtD
Raloxifene—Vertigo—Methotrexate—colon cancer	0.000118	0.00204	CcSEcCtD
Raloxifene—Gastrointestinal pain—Capecitabine—colon cancer	0.000118	0.00204	CcSEcCtD
Raloxifene—Cough—Methotrexate—colon cancer	0.000115	0.00198	CcSEcCtD
Raloxifene—Body temperature increased—Capecitabine—colon cancer	0.000114	0.00197	CcSEcCtD
Raloxifene—Abdominal pain—Capecitabine—colon cancer	0.000114	0.00197	CcSEcCtD
Raloxifene—Chest pain—Methotrexate—colon cancer	0.000112	0.00194	CcSEcCtD
Raloxifene—Myalgia—Methotrexate—colon cancer	0.000112	0.00194	CcSEcCtD
Raloxifene—Arthralgia—Methotrexate—colon cancer	0.000112	0.00194	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000111	0.00192	CcSEcCtD
Raloxifene—Infection—Methotrexate—colon cancer	0.000107	0.00184	CcSEcCtD
Raloxifene—Nervous system disorder—Methotrexate—colon cancer	0.000105	0.00182	CcSEcCtD
Raloxifene—Thrombocytopenia—Methotrexate—colon cancer	0.000105	0.00182	CcSEcCtD
Raloxifene—Skin disorder—Methotrexate—colon cancer	0.000104	0.0018	CcSEcCtD
Raloxifene—Hyperhidrosis—Methotrexate—colon cancer	0.000104	0.00179	CcSEcCtD
Raloxifene—Diarrhoea—Capecitabine—colon cancer	9.86e-05	0.00171	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Methotrexate—colon cancer	9.77e-05	0.00169	CcSEcCtD
Raloxifene—Insomnia—Methotrexate—colon cancer	9.7e-05	0.00168	CcSEcCtD
Raloxifene—Dizziness—Capecitabine—colon cancer	9.53e-05	0.00165	CcSEcCtD
Raloxifene—Dyspepsia—Methotrexate—colon cancer	9.44e-05	0.00163	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Methotrexate—colon cancer	9.26e-05	0.0016	CcSEcCtD
Raloxifene—Pain—Methotrexate—colon cancer	9.17e-05	0.00159	CcSEcCtD
Raloxifene—Vomiting—Capecitabine—colon cancer	9.16e-05	0.00158	CcSEcCtD
Raloxifene—Rash—Capecitabine—colon cancer	9.08e-05	0.00157	CcSEcCtD
Raloxifene—Dermatitis—Capecitabine—colon cancer	9.07e-05	0.00157	CcSEcCtD
Raloxifene—Headache—Capecitabine—colon cancer	9.02e-05	0.00156	CcSEcCtD
Raloxifene—Gastrointestinal pain—Methotrexate—colon cancer	8.77e-05	0.00152	CcSEcCtD
Raloxifene—Nausea—Capecitabine—colon cancer	8.56e-05	0.00148	CcSEcCtD
Raloxifene—Abdominal pain—Methotrexate—colon cancer	8.48e-05	0.00147	CcSEcCtD
Raloxifene—Body temperature increased—Methotrexate—colon cancer	8.48e-05	0.00147	CcSEcCtD
Raloxifene—Diarrhoea—Methotrexate—colon cancer	7.34e-05	0.00127	CcSEcCtD
Raloxifene—Dizziness—Methotrexate—colon cancer	7.09e-05	0.00123	CcSEcCtD
Raloxifene—Vomiting—Methotrexate—colon cancer	6.82e-05	0.00118	CcSEcCtD
Raloxifene—Rash—Methotrexate—colon cancer	6.76e-05	0.00117	CcSEcCtD
Raloxifene—Dermatitis—Methotrexate—colon cancer	6.76e-05	0.00117	CcSEcCtD
Raloxifene—Headache—Methotrexate—colon cancer	6.72e-05	0.00116	CcSEcCtD
Raloxifene—Nausea—Methotrexate—colon cancer	6.37e-05	0.0011	CcSEcCtD
Raloxifene—ESR1—Regulation of Telomerase—MYC—colon cancer	5.07e-05	0.00212	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	5.06e-05	0.00211	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—TGFB1—colon cancer	5.06e-05	0.00211	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	5.05e-05	0.00211	CbGpPWpGaD
Raloxifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.05e-05	0.00211	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CDH1—colon cancer	5e-05	0.00209	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.98e-05	0.00208	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—EGFR—colon cancer	4.96e-05	0.00207	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—MYC—colon cancer	4.95e-05	0.00207	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TGFB1—colon cancer	4.94e-05	0.00207	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	4.91e-05	0.00205	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	4.78e-05	0.002	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CA7—colon cancer	4.66e-05	0.00195	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DLC1—colon cancer	4.61e-05	0.00192	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—BRAF—colon cancer	4.57e-05	0.00191	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CDH1—colon cancer	4.48e-05	0.00187	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—HNF4A—colon cancer	4.45e-05	0.00186	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	4.41e-05	0.00184	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	4.4e-05	0.00184	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ODC1—colon cancer	4.4e-05	0.00184	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CHST5—colon cancer	4.4e-05	0.00184	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	4.39e-05	0.00183	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LGR5—colon cancer	4.33e-05	0.00181	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4.3e-05	0.0018	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—HNF4A—colon cancer	4.25e-05	0.00178	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DLC1—colon cancer	4.2e-05	0.00176	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.15e-05	0.00173	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TP53—colon cancer	4.07e-05	0.0017	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	4.07e-05	0.0017	CbGpPWpGaD
Raloxifene—EBP—Metabolism—ABCB1—colon cancer	4.06e-05	0.00169	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	4.03e-05	0.00169	CbGpPWpGaD
Raloxifene—EBP—Metabolism—TYMS—colon cancer	3.98e-05	0.00166	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LGR5—colon cancer	3.95e-05	0.00165	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CA7—colon cancer	3.95e-05	0.00165	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—PPARG—colon cancer	3.83e-05	0.0016	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CASP3—colon cancer	3.83e-05	0.0016	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.74e-05	0.00156	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CCND1—colon cancer	3.73e-05	0.00156	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	3.69e-05	0.00154	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—HRAS—colon cancer	3.68e-05	0.00154	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.61e-05	0.00151	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—AKT1—colon cancer	3.52e-05	0.00147	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DLC1—colon cancer	3.5e-05	0.00146	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—EP300—colon cancer	3.43e-05	0.00143	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CASP3—colon cancer	3.43e-05	0.00143	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CCND1—colon cancer	3.34e-05	0.0014	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	3.31e-05	0.00138	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LGR5—colon cancer	3.29e-05	0.00138	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	3.25e-05	0.00136	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—AKT1—colon cancer	3.25e-05	0.00136	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—CDKN1A—colon cancer	3.21e-05	0.00134	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AXIN2—colon cancer	3.11e-05	0.0013	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—EP300—colon cancer	3.07e-05	0.00128	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.07e-05	0.00128	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	3.06e-05	0.00128	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	3.06e-05	0.00128	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.05e-05	0.00128	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—MYC—colon cancer	2.99e-05	0.00125	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—EGFR—colon cancer	2.93e-05	0.00122	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	2.91e-05	0.00122	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—NRAS—colon cancer	2.86e-05	0.0012	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.84e-05	0.00119	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AXIN2—colon cancer	2.84e-05	0.00119	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CHST5—colon cancer	2.82e-05	0.00118	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ODC1—colon cancer	2.82e-05	0.00118	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PPARG—colon cancer	2.82e-05	0.00118	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.77e-05	0.00116	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—KRAS—colon cancer	2.76e-05	0.00116	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.74e-05	0.00114	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MYC—colon cancer	2.68e-05	0.00112	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.68e-05	0.00112	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—EGFR—colon cancer	2.62e-05	0.00109	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—EGFR—colon cancer	2.61e-05	0.00109	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—colon cancer	2.6e-05	0.00109	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	2.55e-05	0.00106	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.48e-05	0.00103	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—KRAS—colon cancer	2.47e-05	0.00103	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—KRAS—colon cancer	2.46e-05	0.00103	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—colon cancer	2.46e-05	0.00103	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.41e-05	0.00101	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ODC1—colon cancer	2.39e-05	0.000999	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CHST5—colon cancer	2.39e-05	0.000999	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	2.37e-05	0.000991	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AXIN2—colon cancer	2.37e-05	0.000988	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—PIK3CA—colon cancer	2.3e-05	0.000961	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—PIK3CA—colon cancer	2.26e-05	0.000945	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ABCB1—colon cancer	2.25e-05	0.000939	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	2.24e-05	0.000936	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PTGS2—colon cancer	2.22e-05	0.000928	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.22e-05	0.000927	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.21e-05	0.000925	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—TYMS—colon cancer	2.21e-05	0.000922	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TP53—colon cancer	2.2e-05	0.000919	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—MYC—colon cancer	2.19e-05	0.000914	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.17e-05	0.000907	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—HNF4A—colon cancer	2.14e-05	0.000896	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CA7—colon cancer	2.12e-05	0.000885	CbGpPWpGaD
Raloxifene—AOX1—Disease—FGFR3—colon cancer	2.11e-05	0.00088	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—HRAS—colon cancer	2.09e-05	0.000874	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	2.07e-05	0.000867	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	2.06e-05	0.00086	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	2.05e-05	0.000857	CbGpPWpGaD
Raloxifene—AOX1—Disease—APC—colon cancer	1.93e-05	0.000808	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—PPARG—colon cancer	1.93e-05	0.000808	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	1.9e-05	0.000795	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.88e-05	0.000787	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—AKT1—colon cancer	1.86e-05	0.000776	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—AKT1—colon cancer	1.85e-05	0.000772	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—PPARG—colon cancer	1.85e-05	0.000771	CbGpPWpGaD
Raloxifene—EBP—Metabolism—EP300—colon cancer	1.85e-05	0.000771	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.82e-05	0.000762	CbGpPWpGaD
Raloxifene—AOX1—Disease—BRAF—colon cancer	1.82e-05	0.00076	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.82e-05	0.000759	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PPARG—colon cancer	1.56e-05	0.000653	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.54e-05	0.000643	CbGpPWpGaD
Raloxifene—AOX1—Disease—PTGS2—colon cancer	1.47e-05	0.000614	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.43e-05	0.000597	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PIK3CA—colon cancer	1.37e-05	0.000571	CbGpPWpGaD
Raloxifene—AOX1—Disease—CTNNB1—colon cancer	1.31e-05	0.000549	CbGpPWpGaD
Raloxifene—AOX1—Disease—CDKN1A—colon cancer	1.28e-05	0.000536	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ODC1—colon cancer	1.28e-05	0.000536	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CHST5—colon cancer	1.28e-05	0.000536	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTGS2—colon cancer	1.23e-05	0.000514	CbGpPWpGaD
Raloxifene—AOX1—Disease—EP300—colon cancer	1.22e-05	0.00051	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.19e-05	0.000496	CbGpPWpGaD
Raloxifene—AOX1—Disease—SRC—colon cancer	1.19e-05	0.000496	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ABCB1—colon cancer	1.16e-05	0.000486	CbGpPWpGaD
Raloxifene—AOX1—Disease—NRAS—colon cancer	1.14e-05	0.000478	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—TYMS—colon cancer	1.14e-05	0.000477	CbGpPWpGaD
Raloxifene—EBP—Metabolism—AKT1—colon cancer	1.12e-05	0.000466	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—MYC—colon cancer	1.1e-05	0.000461	CbGpPWpGaD
Raloxifene—AOX1—Disease—MYC—colon cancer	1.06e-05	0.000445	CbGpPWpGaD
Raloxifene—AOX1—Disease—TGFB1—colon cancer	1.06e-05	0.000444	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MYC—colon cancer	1.05e-05	0.00044	CbGpPWpGaD
Raloxifene—AOX1—Disease—EGFR—colon cancer	1.04e-05	0.000435	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—EP300—colon cancer	1.02e-05	0.000427	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.87e-06	0.000413	CbGpPWpGaD
Raloxifene—AOX1—Disease—KRAS—colon cancer	9.84e-06	0.000411	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PPARG—colon cancer	9.31e-06	0.000389	CbGpPWpGaD
Raloxifene—AOX1—Disease—PIK3CA—colon cancer	9.04e-06	0.000378	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGFR3—colon cancer	8.98e-06	0.000375	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.79e-06	0.000367	CbGpPWpGaD
Raloxifene—AOX1—Disease—HRAS—colon cancer	8.36e-06	0.000349	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APC—colon cancer	8.25e-06	0.000345	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—NRAS—colon cancer	8.25e-06	0.000345	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGFR3—colon cancer	8.2e-06	0.000343	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PPARG—colon cancer	8.09e-06	0.000338	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.77e-06	0.000325	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—BRAF—colon cancer	7.75e-06	0.000324	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PIK3CA—colon cancer	7.57e-06	0.000316	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APC—colon cancer	7.53e-06	0.000315	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—NRAS—colon cancer	7.53e-06	0.000315	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EGFR—colon cancer	7.51e-06	0.000314	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ABCB1—colon cancer	7.46e-06	0.000312	CbGpPWpGaD
Raloxifene—AOX1—Disease—AKT1—colon cancer	7.38e-06	0.000308	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TYMS—colon cancer	7.33e-06	0.000306	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—AKT1—colon cancer	7.3e-06	0.000305	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PIK3CA—colon cancer	7.18e-06	0.0003	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—KRAS—colon cancer	7.1e-06	0.000297	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—BRAF—colon cancer	7.08e-06	0.000296	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EGFR—colon cancer	6.86e-06	0.000287	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGFR3—colon cancer	6.83e-06	0.000285	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PIK3CA—colon cancer	6.56e-06	0.000274	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PIK3CA—colon cancer	6.52e-06	0.000273	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—KRAS—colon cancer	6.48e-06	0.000271	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.46e-06	0.00027	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—colon cancer	6.36e-06	0.000266	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ABCB1—colon cancer	6.32e-06	0.000264	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APC—colon cancer	6.27e-06	0.000262	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TYMS—colon cancer	6.21e-06	0.000259	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—AKT1—colon cancer	6.18e-06	0.000258	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HRAS—colon cancer	6.03e-06	0.000252	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PIK3CA—colon cancer	5.95e-06	0.000249	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—BRAF—colon cancer	5.89e-06	0.000246	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—AKT1—colon cancer	5.87e-06	0.000245	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CASP3—colon cancer	5.81e-06	0.000243	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCND1—colon cancer	5.66e-06	0.000236	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CTNNB1—colon cancer	5.6e-06	0.000234	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HRAS—colon cancer	5.51e-06	0.00023	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CDKN1A—colon cancer	5.47e-06	0.000229	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—AKT1—colon cancer	5.36e-06	0.000224	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—AKT1—colon cancer	5.33e-06	0.000223	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MYC—colon cancer	5.31e-06	0.000222	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CASP3—colon cancer	5.31e-06	0.000222	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—EP300—colon cancer	5.29e-06	0.000221	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EP300—colon cancer	5.21e-06	0.000218	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARG—colon cancer	5.19e-06	0.000217	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCND1—colon cancer	5.16e-06	0.000216	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CTNNB1—colon cancer	5.11e-06	0.000214	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SRC—colon cancer	5.06e-06	0.000212	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CDKN1A—colon cancer	5e-06	0.000209	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—colon cancer	4.93e-06	0.000206	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NRAS—colon cancer	4.87e-06	0.000204	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—AKT1—colon cancer	4.86e-06	0.000203	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.78e-06	0.0002	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EP300—colon cancer	4.75e-06	0.000199	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SRC—colon cancer	4.62e-06	0.000193	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MYC—colon cancer	4.54e-06	0.00019	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TGFB1—colon cancer	4.53e-06	0.000189	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—colon cancer	4.5e-06	0.000188	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NRAS—colon cancer	4.45e-06	0.000186	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EGFR—colon cancer	4.44e-06	0.000185	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CASP3—colon cancer	4.42e-06	0.000185	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARG—colon cancer	4.4e-06	0.000184	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCND1—colon cancer	4.3e-06	0.00018	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CTNNB1—colon cancer	4.26e-06	0.000178	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KRAS—colon cancer	4.19e-06	0.000175	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CDKN1A—colon cancer	4.16e-06	0.000174	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MYC—colon cancer	4.14e-06	0.000173	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TGFB1—colon cancer	4.13e-06	0.000173	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—colon cancer	4.08e-06	0.000171	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EGFR—colon cancer	4.05e-06	0.000169	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EP300—colon cancer	3.96e-06	0.000165	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CA—colon cancer	3.91e-06	0.000164	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CA—colon cancer	3.85e-06	0.000161	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SRC—colon cancer	3.85e-06	0.000161	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KRAS—colon cancer	3.83e-06	0.00016	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—colon cancer	3.75e-06	0.000157	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—colon cancer	3.73e-06	0.000156	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NRAS—colon cancer	3.7e-06	0.000155	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—AKT1—colon cancer	3.68e-06	0.000154	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HRAS—colon cancer	3.56e-06	0.000149	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CA—colon cancer	3.52e-06	0.000147	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—colon cancer	3.46e-06	0.000145	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MYC—colon cancer	3.45e-06	0.000144	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFB1—colon cancer	3.44e-06	0.000144	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—colon cancer	3.4e-06	0.000142	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—EP300—colon cancer	3.4e-06	0.000142	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ABCB1—colon cancer	3.39e-06	0.000142	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EGFR—colon cancer	3.38e-06	0.000141	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TYMS—colon cancer	3.33e-06	0.000139	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HRAS—colon cancer	3.25e-06	0.000136	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AKT1—colon cancer	3.2e-06	0.000134	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KRAS—colon cancer	3.19e-06	0.000133	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT1—colon cancer	3.15e-06	0.000132	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CA—colon cancer	2.93e-06	0.000122	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—EP300—colon cancer	2.88e-06	0.00012	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT1—colon cancer	2.87e-06	0.00012	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—colon cancer	2.83e-06	0.000118	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HRAS—colon cancer	2.71e-06	0.000113	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CA—colon cancer	2.51e-06	0.000105	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT1—colon cancer	2.39e-06	0.0001	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARG—colon cancer	2.36e-06	9.86e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CA—colon cancer	2.13e-06	8.89e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKT1—colon cancer	2.05e-06	8.58e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—colon cancer	1.86e-06	7.76e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKT1—colon cancer	1.74e-06	7.26e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—EP300—colon cancer	1.54e-06	6.45e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CA—colon cancer	1.14e-06	4.77e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKT1—colon cancer	9.33e-07	3.9e-05	CbGpPWpGaD
